Trexquant Investment LP Aravive, Inc. Transaction History

Trexquant Investment LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$3.67 - $5.8 $41,034 - $64,849	-11,181 Closed	0 $0
Q2 2021 Aug 12, 2021	SELL	$4.65 - $6.42 $119,300 - $164,711	-25,656 Reduced 69.65%	11,181 $67,000
Q1 2021 May 13, 2021	BUY	$5.11 - $9.24 $93,242 - $168,602	18,247 Added 98.15%	36,837 $243,000
Q4 2020 Feb 11, 2021	BUY	$4.36 - $6.51 $81,052 - $121,020	18,590 New	18,590 $105,000

28.1K

Ticker ARAV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,518,300
Description
Aravive, Inc., a clinical-stage biopharmaceutical company, develops treatments for life-threatening diseases, including cancer and fibrosis in the United States. Its lead product candidate is batiraxcept, an ultrahigh-affinity, decoy protein that targets the GAS6-AXL signaling pathway, which is in Phase III clinical trial for the treatment of pl...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.